Inactivation of nuclear factor κB by MIP-based drug combinations augments cell death of breast cancer cells
Background: Drug combination therapy to treat cancer is a strategic approach to increase successful treatment rate. Optimizing combination regimens is vital to increase therapeutic efficacy with minimal side effects. Materials and methods: In the present study, we evaluated the in vitro cytotoxicity...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Published: |
Dove Medical Press
2018
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/20607/ https://doi.org/10.2147/DDDT.S141925 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|